June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Characterization of the prevalence of visual impairment, ocular comorbidities, and mental health conditions in the United States
Author Affiliations & Notes
  • Neha Sharma
    Case Western Reserve University School of Medicine, Cleveland, Ohio, United States
  • Jeffrey Chu
    Case Western Reserve University School of Medicine, Cleveland, Ohio, United States
  • Jacqueline K. Shaia
    Case Western Reserve University School of Medicine, Cleveland, Ohio, United States
  • Rishi Singh
    Cleveland Clinic Martin North Hospital, Stuart, Florida, United States
    Cleveland Clinic Cole Eye Institute, Cleveland, Ohio, United States
  • Katherine Talcott
    Cleveland Clinic Cole Eye Institute, Cleveland, Ohio, United States
  • Footnotes
    Commercial Relationships   Neha Sharma None; Jeffrey Chu None; Jacqueline Shaia None; Rishi Singh Genentech/Roche, Alcon, Novartis, Regeneron, Asclepix, Gyroscope, Bausch and Lomb, Apellis, Code F (Financial Support); Katherine Talcott Genentech/Roche, Apellis, Eyepoint, Zeiss, Regenxbio, Code F (Financial Support)
  • Footnotes
    Support  P30EY025585(BA-A), Research to Prevent Blindness (RPB) Challenge Grant, Cleveland Eye Bank Foundation Grant
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 1908. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Neha Sharma, Jeffrey Chu, Jacqueline K. Shaia, Rishi Singh, Katherine Talcott; Characterization of the prevalence of visual impairment, ocular comorbidities, and mental health conditions in the United States. Invest. Ophthalmol. Vis. Sci. 2023;64(8):1908.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : It is not well understood which ocular comorbidities pose the greatest risk for having a mental health condition and if there are differences across sex and racial demographics. This study evaluated the odds of having a mental health condition with an ocular condition with or without visual impairment across different demographics.

Methods : A cross-sectional study was conducted using the TriNetX Analytics Network, a United States database consisting of over 87 million patients. ICD-10 codes were utilized to identify patients with diabetic retinopathy (DR), age related macular degeneration (AMD), retinal vein occlusion (RVO), glaucoma, uveitis, visual impairment (low vision or blindness), and a mental health condition (depression, suicide attempt or ideation, or anxiety). Prevalence odds were stratified by sex and racial demographics. Statistical analyses were completed using RStudio and Excel and utilized 95% confidence intervals.

Results : Among patients with no visual impairment, the prevalence odds ratios of every mental health condition were higher for patients with AMD compared to any other single ocular condition. The ocular condition with the highest prevalence of depression was DR (7.65%) and the highest prevalence of anxiety was observed among glaucoma patients (9.73%). Among patients with visual impairment, the prevalence of depression (16.50%) and anxiety (12.53%) was the highest among RVO patients compared to any other ocular condition. The highest prevalence of visual impairment was observed in white female patients with anxiety and AMD (17.47%). Male Hispanic patients with depression and RVO had the highest odds for visual impairment (POR 7.49; 95% CI 6.36, 16.7). Compared to white males, female Hispanic patients with RVO had the highest prevalence odds for anxiety (POR 7.06; 3.17, 11.72).

Conclusions : The addition of visual impairment alongside an ocular condition yielded increased prevalence and prevalence odds of mental health conditions, specifically depression and anxiety. Male and female Hispanic patients with RVO are also disproportionately affected by depression and anxiety, respectively, compared to white males. These findings demonstrate which ocular conditions pose an increased risk for mental conditions and an increased need to screen minority patients who have increased prevalence odds for depression and anxiety.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×